Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neogenomics Inc (NEO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neogenomics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1077183.
Total stock buying since 2015: $2,158,610.
Total stock sales since 2015: $372,603,469.
Total stock option exercises since 2015: $33,923,832.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 113,010 | $797,551 | 0 | $0 | 158,153 | $0 |
| 2024 | 0 | $0 | 13,874 | $215,766 | 252,120 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 1,507 | $17,481 |
| 2022 | 0 | $0 | 3,209 | $58,692 | 16,161 | $123,952 |
| 2021 | 17,000 | $520,710 | 478,521 | $18,765,432 | 349,751 | $5,102,096 |
| 2020 | 0 | $0 | 1,815,127 | $70,726,519 | 1,264,895 | $10,112,498 |
| 2019 | 0 | $0 | 1,913,033 | $42,348,765 | 1,569,627 | $10,691,323 |
| 2018 | 26,000 | $301,600 | 16,536,400 | $221,356,668 | 664,899 | $2,729,275 |
| 2017 | 20,000 | $183,800 | 167,990 | $1,327,287 | 353,331 | $814,919 |
| 2016 | 22,007 | $149,195 | 1,824,807 | $14,689,025 | 2,482,168 | $4,251,876 |
| 2015 | 25,950 | $205,754 | 385,000 | $3,115,315 | 51,218 | $80,412 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 37,900 | $212,273 | 0 | $0 | 0 | $0 |
| 2025-06 | 0 | $0 | 0 | $0 | 19,414 | $0 |
| 2025-05 | 75,110 | $585,278 | 0 | $0 | 40,462 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 98,277 | $0 |
| 2024-11 | 0 | $0 | 5,175 | $79,477 | 0 | $0 |
| 2024-08 | 0 | $0 | 0 | $0 | 90,688 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 161,432 | $0 |
| 2024-03 | 0 | $0 | 6,112 | $97,578 | 0 | $0 |
| 2024-02 | 0 | $0 | 2,587 | $38,711 | 0 | $0 |
| 2023-05 | 0 | $0 | 0 | $0 | 1,507 | $17,481 |
| 2022-05 | 0 | $0 | 0 | $0 | 3,334 | $24,238 |
| 2022-04 | 0 | $0 | 0 | $0 | 5,727 | $43,067 |
| 2022-03 | 0 | $0 | 3,209 | $58,692 | 5,000 | $37,600 |
| 2022-01 | 0 | $0 | 0 | $0 | 2,100 | $19,047 |
| 2021-12 | 17,000 | $520,710 | 1,846 | $64,610 | 8,334 | $69,588 |
| 2021-11 | 0 | $0 | 125,000 | $4,624,248 | 50,000 | $388,749 |
| 2021-06 | 0 | $0 | 221,071 | $8,942,531 | 22,123 | $375,145 |
| 2021-05 | 0 | $0 | 130,604 | $5,134,043 | 126,958 | $2,368,147 |
| 2021-04 | 0 | $0 | 0 | $0 | 25,050 | $477,202 |
| 2021-01 | 0 | $0 | 0 | $0 | 117,286 | $1,423,265 |
| 2020-12 | 0 | $0 | 267,883 | $13,209,543 | 132,004 | $1,426,025 |
| 2020-11 | 0 | $0 | 542,262 | $23,235,227 | 665,000 | $5,005,748 |
| 2020-09 | 0 | $0 | 410,733 | $15,084,418 | 8,333 | $75,913 |
| 2020-08 | 0 | $0 | 117,500 | $4,606,045 | 145,000 | $1,056,510 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-06 | Zook Anthony P. (Chief Executive Officer) | Buy | 17,900 | 5.58 | 99,953 |
| 2025-08-06 | Sherman Jeffrey Scott (Chief Financial Officer) | Buy | 20,000 | 5.62 | 112,320 |
| 2025-06-01 | Kanovsky Stephen M (Director) | Option Ex | 12,254 | .00 | 0 |
| 2025-06-01 | Williams Felicia (Director) | Option Ex | 7,160 | .00 | 0 |
| 2025-05-27 | Kelly Michael Aaron (Director) | Buy | 5,000 | 7.60 | 38,000 |
| 2025-05-12 | Stone Warren (Pres & Chief Operating Officer) | Buy | 5,700 | 8.58 | 48,894 |
| 2025-05-11 | Stone Warren (Pres & Chief Operating Officer) | Option Ex | 9,613 | .00 | 0 |
| 2025-05-11 | Olivo Alicia C (EVP, GC & Business Development) | Option Ex | 6,503 | .00 | 0 |
| 2025-05-11 | Sherman Jeffrey Scott (Chief Financial Officer) | Option Ex | 13,005 | .00 | 0 |
| 2025-05-09 | Tetrault Lynn A. (Director) | Buy | 7,000 | 8.14 | 56,972 |
| 2025-05-07 | Kanovsky Stephen M (Director) | Buy | 4,000 | 7.78 | 31,124 |
| 2025-05-06 | Zook Anthony P. (Chief Executive Officer) | Buy | 18,900 | 7.88 | 148,913 |
| 2025-05-05 | Gunn Neil (Director) | Buy | 4,510 | 7.75 | 34,975 |
| 2025-05-05 | Perez David Brian (Director) | Buy | 10,000 | 7.63 | 76,300 |
| 2025-05-02 | Stone Warren (Pres & Chief Operating Officer) | Option Ex | 5,969 | .00 | 0 |
| 2025-05-02 | Aunan Greg D (Chief Accounting Officer) | Option Ex | 5,372 | .00 | 0 |
| 2025-05-02 | Sherman Jeffrey Scott (Chief Financial Officer) | Buy | 20,000 | 7.50 | 150,100 |
| 2025-02-23 | Stone Warren (Chief Commerical Officer) | Option Ex | 8,443 | .00 | 0 |
| 2025-02-23 | Olivo Alicia C (EVP, GC & Business Development) | Option Ex | 8,443 | .00 | 0 |
| 2025-02-23 | Harris Melody (Chf Ops Off, Pres, Informatics) | Option Ex | 8,443 | .00 | 0 |
| 2025-02-23 | Sherman Jeffrey Scott (Chief Financial Officer) | Option Ex | 15,535 | .00 | 0 |
| 2025-02-23 | Smith Christopher M (Chief Executive Officer) | Option Ex | 57,413 | .00 | 0 |
| 2024-11-15 | Olivo Alicia C (General Counsel) | Sale | 5,175 | 15.36 | 79,477 |
| 2024-08-10 | Gunn Neil (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Floegel Elizabeth (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Kelly Michael Aaron (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Perez David Brian (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Kanovsky Stephen M (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Hannah Alison L. (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Tetrault Lynn A. (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-08-10 | Zook Anthony P. (Director) | Option Ex | 11,336 | .00 | 0 |
| 2024-05-11 | Stone Warren (Chief Commerical Officer) | Option Ex | 19,224 | .00 | 0 |
| 2024-05-11 | Olivo Alicia C (General Counsel) | Option Ex | 13,004 | .00 | 0 |
| 2024-05-11 | Harris Melody (Chf Ops Off, Pres, Informatics) | Option Ex | 7,068 | .00 | 0 |
| 2024-05-11 | Sherman Jeffrey Scott (Chief Financial Officer) | Option Ex | 26,010 | .00 | 0 |
| 2024-05-11 | Smith Christopher M (Chief Executive Officer) | Option Ex | 96,126 | .00 | 0 |
| 2024-03-04 | Tetrault Lynn A. (Director) | Sale | 6,112 | 15.96 | 97,578 |
| 2024-02-15 | Olivo Alicia C (General Counsel) | Sale | 2,587 | 14.96 | 38,711 |
| 2023-05-22 | Tetrault Lynn A. | Option Ex | 1,507 | 11.60 | 17,481 |
| 2022-05-18 | Tetrault Lynn A. | Option Ex | 3,334 | 7.27 | 24,238 |
| 2022-04-28 | Bonello William (Chief Financial Officer) | Option Ex | 5,727 | 7.52 | 43,067 |
| 2022-03-08 | Bonello William (Chief Financial Officer) | Option Ex | 5,000 | 7.52 | 37,600 |
| 2022-03-07 | Bonello William (Chief Financial Officer) | Sale | 3,209 | 18.29 | 58,692 |
| 2022-01-11 | Mckenzie Kathryn B (Chief Sustainability/Risk Ofcr) | Option Ex | 2,100 | 9.07 | 19,047 |
| 2021-12-22 | Mckenzie Kathryn B (Chief Financial Officer) | Option Ex | 5,000 | 9.07 | 45,350 |
| 2021-12-22 | Johnson Kevin C | Option Ex | 3,334 | 7.27 | 24,238 |
| 2021-12-21 | Mckenzie Kathryn B (Chief Financial Officer) | Sale | 1,846 | 35.00 | 64,610 |
| 2021-12-06 | Mallon Mark (Chief Executive Officer) | Buy | 17,000 | 30.63 | 520,710 |
| 2021-11-30 | Bonello William (President, Informatics) | Option Ex | 25,000 | 7.52 | 188,000 |
| 2021-11-26 | Brown Douglas Matthew (Chief Strategy Officer) | Sale | 33,334 | 36.85 | 1,228,357 |
| 2021-11-24 | Brown Douglas Matthew (Chief Strategy Officer) | Sale | 33,333 | 36.84 | 1,227,987 |
| 2021-11-24 | Bonello William (President, Informatics) | Sale | 25,000 | 37.13 | 928,250 |
| 2021-11-24 | Bonello William (President, Informatics) | Option Ex | 25,000 | 8.03 | 200,749 |
| 2021-11-23 | Brown Douglas Matthew (Chief Strategy Officer) | Sale | 33,333 | 37.19 | 1,239,654 |
| 2021-06-11 | Tetrault Lynn A. | Option Ex | 1,389 | 9.11 | 12,653 |
| 2021-06-08 | Crowther Bruce K | Sale | 20,734 | 41.46 | 859,631 |
| 2021-06-08 | Crowther Bruce K | Option Ex | 20,734 | 17.48 | 362,492 |
| 2021-06-03 | Cardoza George (President, Pharma Services) | Sale | 31,107 | 40.11 | 1,247,701 |
| 2021-06-02 | Cardoza George (President, Pharma Services) | Sale | 169,230 | 40.39 | 6,835,199 |
| 2021-05-25 | Shovlin Robert J. (President, Clinical Services) | Sale | 130,604 | 39.31 | 5,134,043 |
| 2021-05-25 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 126,958 | 18.65 | 2,368,147 |
| 2021-04-22 | Weiss Lawrence Martin (Chief Medical Officer) | Option Ex | 25,050 | 19.05 | 477,202 |
| 2021-01-07 | Jones Steven C | Option Ex | 117,286 | 12.13 | 1,423,265 |
| 2020-12-14 | Weiss Lawrence Martin (Chief Medical Officer) | Sale | 20,200 | 51.06 | 1,031,412 |
| 2020-12-14 | Weiss Lawrence Martin (Chief Medical Officer) | Option Ex | 109,004 | 11.39 | 1,241,337 |
| 2020-12-14 | Jones Steven C | Sale | 25,000 | 51.67 | 1,291,750 |
| 2020-12-11 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 15,000 | 49.99 | 749,850 |
| 2020-12-11 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 15,000 | 8.03 | 120,449 |
| 2020-12-11 | Jones Steven C | Sale | 25,000 | 50.52 | 1,263,000 |
| 2020-12-10 | Jones Steven C | Sale | 20,000 | 50.30 | 1,006,000 |
| 2020-12-07 | Jones Steven C | Sale | 45,658 | 49.45 | 2,257,788 |
| 2020-12-04 | Jones Steven C | Sale | 64,394 | 48.07 | 3,095,419 |
| 2020-12-04 | Johnson Kevin C | Sale | 24,683 | 47.88 | 1,181,822 |
| 2020-12-03 | Jones Steven C | Sale | 19,948 | 48.03 | 958,102 |
| 2020-12-02 | Bonello William (President, Informatics) | Sale | 8,000 | 46.80 | 374,400 |
| 2020-12-02 | Bonello William (President, Informatics) | Option Ex | 8,000 | 8.03 | 64,239 |
| 2020-11-25 | Cardoza George (President, Pharma Services) | Sale | 77,074 | 45.48 | 3,505,325 |
| 2020-11-25 | Cardoza George (President, Pharma Services) | Option Ex | 77,074 | 7.52 | 579,596 |
| 2020-11-24 | Cardoza George (President, Pharma Services) | Sale | 52,926 | 45.19 | 2,391,725 |
| 2020-11-24 | Cardoza George (President, Pharma Services) | Option Ex | 72,926 | 7.52 | 548,403 |
| 2020-11-16 | Van Oort Douglas M (Chairman and CEO) | Sale | 100,000 | 42.34 | 4,234,000 |
| 2020-11-16 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 20,000 | 7.52 | 150,400 |
| 2020-11-16 | Hipp Raymond R | Sale | 70,000 | 42.28 | 2,959,600 |
| 2020-11-13 | Van Oort Douglas M (Chairman and CEO) | Sale | 118,752 | 41.56 | 4,935,333 |
| 2020-11-13 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 358,752 | 7.52 | 2,697,815 |
| 2020-11-12 | Van Oort Douglas M (Chairman and CEO) | Sale | 121,248 | 42.18 | 5,114,240 |
| 2020-11-12 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 121,248 | 7.52 | 911,784 |
| 2020-11-10 | Pedulla Denise E (General Counsel) | Sale | 2,262 | 42.00 | 95,004 |
| 2020-11-10 | Pedulla Denise E (General Counsel) | Option Ex | 15,000 | 7.85 | 117,750 |
| 2020-09-29 | Jones Steven C | Sale | 222,049 | 36.75 | 8,160,300 |
| 2020-09-28 | Jones Steven C | Sale | 57,951 | 36.45 | 2,112,313 |
| 2020-09-24 | Crowther Bruce K | Sale | 8,333 | 35.01 | 291,738 |
| 2020-09-24 | Crowther Bruce K | Option Ex | 8,333 | 9.11 | 75,913 |
| 2020-09-22 | Crowther Bruce K | Sale | 2,400 | 35.68 | 85,632 |
| 2020-09-10 | Jones Steven C | Sale | 37,991 | 37.13 | 1,410,605 |
| 2020-09-09 | Jones Steven C | Sale | 71,583 | 36.98 | 2,647,139 |
| 2020-09-08 | Jones Steven C | Sale | 10,426 | 36.13 | 376,691 |
| 2020-08-06 | Hannah Alison L. | Option Ex | 10,000 | 7.27 | 72,700 |
| 2020-08-06 | Cardoza George (President, Pharma Services) | Sale | 82,500 | 39.35 | 3,246,375 |
| 2020-08-06 | Cardoza George (President, Pharma Services) | Option Ex | 100,000 | 7.15 | 715,000 |
| 2020-08-03 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 13,000 | 39.25 | 510,250 |
| 2020-08-03 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 13,000 | 7.52 | 97,760 |
| 2020-08-03 | Bonello William (President, Informatics) | Sale | 22,000 | 38.61 | 849,420 |
| 2020-08-03 | Bonello William (President, Informatics) | Option Ex | 22,000 | 7.78 | 171,050 |
| 2020-07-30 | Shovlin Robert J. (President, Clinical Services) | Sale | 81,356 | 38.17 | 3,105,358 |
| 2020-07-30 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 83,391 | 13.56 | 1,130,781 |
| 2020-05-01 | Crowther Bruce K | Option Ex | 10,000 | 4.78 | 47,800 |
| 2020-03-13 | Jones Steven C | Option Ex | 125,000 | 4.78 | 597,500 |
| 2020-03-04 | Shovlin Robert J. (President, Clinical Services) | Sale | 98,093 | 30.86 | 3,027,149 |
| 2020-03-04 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 96,167 | 8.03 | 772,221 |
| 2020-03-02 | Jones Steven C | Sale | 297,300 | 28.45 | 8,458,779 |
| 2019-12-30 | Jones Steven C | Option Ex | 100,000 | 4.78 | 478,000 |
| 2019-12-10 | Mckenzie Kathryn B (Chief Accounting Officer) | Sale | 8,000 | 26.37 | 210,960 |
| 2019-12-10 | Mckenzie Kathryn B (Chief Accounting Officer) | Option Ex | 8,000 | 8.03 | 64,239 |
| 2019-11-21 | Jones Steven C | Sale | 23,162 | 24.27 | 562,141 |
| 2019-11-20 | Jones Steven C | Sale | 128,068 | 24.35 | 3,118,455 |
| 2019-11-19 | Van Oort Douglas M (Chairman and CEO) | Sale | 187,500 | 24.08 | 4,515,000 |
| 2019-11-15 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 6,833 | 23.45 | 160,233 |
| 2019-11-15 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 6,833 | 7.78 | 53,126 |
| 2019-11-12 | Cardoza George (President, Pharma Services) | Sale | 19,444 | 23.15 | 450,128 |
| 2019-11-12 | Cardoza George (President, Pharma Services) | Option Ex | 44,444 | 7.15 | 317,774 |
| 2019-11-08 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 472,527 | 7.15 | 3,378,568 |
| 2019-11-07 | Cardoza George (President, Pharma Services) | Sale | 4,000 | 22.80 | 91,200 |
| 2019-11-06 | Cardoza George (President, Pharma Services) | Sale | 51,556 | 22.82 | 1,176,507 |
| 2019-11-06 | Cardoza George (President, Pharma Services) | Option Ex | 55,556 | 7.15 | 397,225 |
| 2019-11-01 | Shovlin Robert J. (President, Clinical Services) | Sale | 35,801 | 22.74 | 814,114 |
| 2019-10-31 | Shovlin Robert J. (President, Clinical Services) | Sale | 70,473 | 23.11 | 1,628,631 |
| 2019-10-31 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 96,166 | 8.03 | 772,212 |
| 2019-10-31 | Johnson Kevin C | Option Ex | 24,683 | 8.19 | 202,153 |
| 2019-09-10 | Jones Steven C | Sale | 1,200 | 21.47 | 25,764 |
| 2019-09-09 | Hannah Alison L. | Option Ex | 11,666 | 7.88 | 91,986 |
| 2019-09-09 | Jones Steven C | Sale | 3 | 25.00 | 75 |
| 2019-09-06 | Jones Steven C | Sale | 1,691 | 25.00 | 42,275 |
| 2019-08-30 | Jones Steven C | Sale | 1,200 | 25.00 | 30,000 |
| 2019-08-28 | Jones Steven C | Sale | 39,537 | 25.02 | 989,215 |
| 2019-08-28 | Bonello William (Chief Strategy Officer) | Sale | 17,000 | 24.83 | 422,110 |
| 2019-08-28 | Bonello William (Chief Strategy Officer) | Option Ex | 17,000 | 7.52 | 127,840 |
| 2019-08-27 | Jones Steven C | Sale | 30,280 | 24.95 | 755,486 |
| 2019-08-26 | Jones Steven C | Sale | 143,603 | 24.87 | 3,571,406 |
| 2019-08-26 | Johnson Kevin C | Sale | 11,800 | 24.74 | 291,932 |
| 2019-08-26 | Hipp Raymond R | Sale | 15,424 | 24.79 | 382,360 |
| 2019-08-23 | Jones Steven C | Sale | 7,456 | 25.72 | 191,768 |
| 2019-08-23 | Johnson Kevin C | Sale | 41,200 | 25.60 | 1,054,720 |
| 2019-08-23 | Hipp Raymond R | Sale | 600 | 25.02 | 15,012 |
| 2019-08-23 | Hipp Raymond R | Option Ex | 9,127 | 9.33 | 85,127 |
| 2019-05-08 | Hipp Raymond R | Sale | 118,479 | 22.36 | 2,649,190 |
| 2019-05-07 | Hipp Raymond R | Sale | 31,521 | 22.61 | 712,689 |
| 2019-05-06 | Bonello William (Chief Strategy Officer) | Sale | 7,200 | 23.53 | 169,416 |
| 2019-05-06 | Bonello William (Chief Strategy Officer) | Option Ex | 7,200 | 7.52 | 54,144 |
| 2019-05-03 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 30,000 | 22.74 | 682,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of NEO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neogenomics Inc (symbol NEO, CIK number 1077183) see the Securities and Exchange Commission (SEC) website.